Moderna Inc.

NAS: MRNA

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Moderna Inc.

Countdown to close

--Real time quotes

Jan 31, 2023, 3:56 p.m.

MRNA

/zigman2/quotes/205619834/composite

175.74

Change

-5.13 -2.84%

Volume

Volume 4.90m

Real time quotes

/zigman2/quotes/205619834/composite

Previous close

$ 180.87

$ 175.74

Change

-5.13 -2.84%

Day low

Day high

$173.78

$180.21

52 week low

52 week high

$115.03

$217.25

Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Moderna Inc.

View Ratios

Fiscal year is January-December. All values USD millions.	2017	2018	2019	2020	2021	5-year trend
Sales/Revenue	205.83M	135.07M	60.21M	803.4M	18.41B
Sales Growth	-	-34.38%	-55.42%	1,234.34%	2,191.90%
Cost of Goods Sold (COGS) incl. D&A	20.54M	24.86M	31.02M	39.18M	2.85B
COGS excluding D&A	-	-	-	7.93M	2.62B
Depreciation & Amortization Expense	20.54M	24.86M	31.02M	31.25M	232M
Depreciation	20.54M	24.86M	31.02M	31.25M	232M
Amortization of Intangibles	-	-	-	-	-
COGS Growth	-	21.06%	24.77%	26.31%	7,170.82%
Gross Income	185.29M	110.21M	29.19M	764.21M	15.56B
Gross Income Growth	-	-40.52%	-73.52%	2,518.24%	1,936.61%
Gross Profit Margin	-	-	-	-	84.53%	NA

	2017	2018	2019	2020	2021	5-year trend
SG&A Expense	454.64M	579.07M	574.91M	1.53B	2.33B
Research & Development	410.46M	509.68M	465.29M	1.34B	1.76B
Other SG&A	44.19M	69.39M	109.62M	188.27M	-
SGA Growth	-	27.37%	-0.72%	165.67%	52.29%
Other Operating Expense	-	-	-	-	-
Unusual Expense	-	-	-	1.6M	-
EBIT after Unusual Expense	-	-	-	(764.74M)	-
Non Operating Income/Expense	(1.74M)	4.93M	(914,000)	5.4M	47M
Non-Operating Interest Income	15.24M	27.02M	38.53M	24.72M	18M
Equity in Affiliates (Pretax)	-	-	-	-	-
Interest Expense	132,000	3.1M	6.61M	9.89M	18M
Interest Expense Growth	-	2,245.45%	113.57%	49.52%	82.08%
Gross Interest Expense	132,000	3.1M	6.61M	9.89M	18M
Interest Capitalized	-	-	-	-	-
Pretax Income	(256M)	(440.01M)	(514.72M)	(744.51M)	13.29B
Pretax Income Growth	-	-71.88%	-16.98%	-44.65%	1,884.39%
Pretax Margin	-	-	-	-	72.15%	NA
Income Tax	(80,000)	(55.27M)	(695,000)	2.55M	1.08B
Income Tax - Current Domestic	(80,000)	326,000	505,000	32,000	1.34B
Income Tax - Current Foreign	-	-	-	2.52M	40M
Income Tax - Deferred Domestic	-	-	(1.2M)	-	(294M)
Income Tax - Deferred Foreign	-	-	-	-	(2M)
Income Tax Credits	-	55.6M	-	-	-
Equity in Affiliates	-	-	-	-	-
Other After Tax Income (Expense)	-	(4.13M)	-	-	-
Consolidated Net Income	(255.92M)	(388.86M)	(514.02M)	(747.06M)	12.2B
Minority Interest Expense	-	-	-	-	-
Net Income	(255.92M)	(388.86M)	(514.02M)	(747.06M)	12.2B
Net Income Growth	-	-51.95%	-32.19%	-45.34%	1,733.33%
Net Margin Growth	-	-	-	-	66.27%	NA
Extraordinaries & Discontinued Operations	-	-	-	-	-
Extra Items & Gain/Loss Sale Of Assets	-	-	-	-	-
Cumulative Effect - Accounting Chg	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Net Income After Extraordinaries	(255.92M)	(388.86M)	(514.02M)	(747.06M)	12.2B
Preferred Dividends	13.93M	13M	-	-	-
Net Income Available to Common	(269.84M)	(401.86M)	(514.02M)	(747.06M)	12.2B
EPS (Basic)	(1.92)	(4.95)	(1.55)	(1.96)	30.28
EPS (Basic) Growth	-	-158.38%	68.63%	-26.08%	1,645.50%
Basic Shares Outstanding	140.6M	81.11M	330.8M	381.33M	403M
EPS (Diluted)	(1.92)	(4.95)	(1.55)	(1.96)	28.31
EPS (Diluted) Growth	-	-158.38%	68.63%	-26.08%	1,545.10%
Diluted Shares Outstanding	140.6M	81.11M	330.8M	381.33M	431M
EBITDA	(248.82M)	(444M)	(514.7M)	(731.89M)	13.47B
EBITDA Growth	-	-78.44%	-15.92%	-42.20%	1,940.43%
EBITDA Margin	-	-	-	-	73.15%	NA

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Moderna Inc.

Annual Financials for Moderna Inc.

Latest News

dow

nasdaq

s&p 500

Kiosk